TrianglePUBLICATIONS · 2642539
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1989 Jan
- First author
- Harousseau JL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Harousseau JL
- type
- Author
- name
- Reiffers J
- type
- Author
- name
- Hurteloup P
- type
- Author
- name
- Milpied N
- type
- Author
- name
- Guy H
- type
- Author
- name
- Rigal-Huguet F
- type
- Author
- name
- Facon T
- type
- Author
- name
- Dufour P
- type
- Author
- name
- Ifrah N
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Harousseau JL
- type
- Author
- name
- Reiffers J
- type
- Author
- name
- Hurteloup P
- type
- Author
- name
- Milpied N
- type
- Author
- name
- Guy H
- type
- Author
- name
- Rigal-Huguet F
- type
- Author
- name
- Facon T
- type
- Author
- name
- Dufour P
- type
- Author
- name
- Ifrah N
- type
- Author
- bibliography ids
- nci-bib-18ea7bcacf7eeb2f5c3d62fa
- book metadata
- content sha256
- 25c13b5a26dd35de5a322fa542505b1215e30387be2fadd68e24754a3bc7fec1
- document type
- citation
- dois
- 10.1200/JCO.1989.7.1.45
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:2642539
- immutable id
- pubmed:2642539@25c13b5a26dd35de5a322fa542505b1215e30387be2fadd68e24754a3bc7fec1
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 45-9
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 2642539
- provenance
- batch id
- a200ed3d3f0da2c0bb77
- provider
- NCBI PubMed ESummary
- record sha256
- 25fe591c88d17d1c6e882c4b6e6dbfb5bdf3ac20d1b1b490234f3550fa627fec
- response sha256
- fca9a34da948816f71802a739926070ea93d0f46ed836320bb1feb42dde1561e
- retrieved at
- 2026-09-09T23:45:10.684024+00:00
- publication date
- display
- 1989 Jan
- precision
- month
- year
- 1989
- publication types
- Clinical Trial
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/2642539/
- title
- Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine.
Preserved source evidence · Not medical advice